News from invo bioscience, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 15, 2023, 16:05 ET INVO Reports First Quarter 2023 Financial Results

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

May 08, 2023, 16:15 ET INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced infertility treatment worldwide...

Apr 17, 2023, 16:05 ET INVO Reports Fourth Quarter and Full Year 2022 Financial Results

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Apr 11, 2023, 17:30 ET INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced infertility treatment worldwide...

Apr 05, 2023, 09:00 ET INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Mar 30, 2023, 17:25 ET INVO Provides Preliminary Update on FY2022 Financial Results

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Mar 27, 2023, 17:06 ET INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Mar 24, 2023, 08:00 ET INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Mar 20, 2023, 09:00 ET INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Jan 05, 2023, 09:00 ET INVO Bioscience Enters Distribution Agreement for Taiwan

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Jan 03, 2023, 09:00 ET INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Nov 30, 2022, 09:30 ET First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Nov 14, 2022, 17:40 ET INVO Bioscience Reports Third Quarter 2022 Financial Results

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Nov 10, 2022, 16:15 ET INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Nov 01, 2022, 09:00 ET INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo

- The multi-billion-dollar global fertility market is predicted to reach approximately US$47.9 billion by 2030, yet remains severely underserved with ...

Oct 21, 2022, 09:00 ET INVOcell Review Published in Current Opinion in Obstetrics and Gynecology

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Oct 17, 2022, 09:00 ET INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo

INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), ...

Sep 22, 2022, 09:00 ET Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Aug 25, 2022, 09:00 ET INVOcell Launched in Malaysia by Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz

INVO Bioscience, Inc. (Nasdaq: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Aug 15, 2022, 16:05 ET INVO Bioscience Reports Second Quarter 2022 Financial Results

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

Aug 04, 2022, 16:15 ET INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

Jul 07, 2022, 08:00 ET INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

May 16, 2022, 16:15 ET INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

May 16, 2022, 16:05 ET INVO Bioscience Reports First Quarter 2022 Financial Results

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced...

May 09, 2022, 16:30 ET INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022

INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...